Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The contribution of B cells to transplantation tolerance
Luis Graca
Luis Graca
Published May 26, 2020
Citation Information: J Clin Invest. 2020;130(7):3406-3408. https://doi.org/10.1172/JCI138122.
View: Text | PDF
Commentary

The contribution of B cells to transplantation tolerance

  • Text
  • PDF
Abstract

Since it was shown in the early 1950s that it is possible to induce transplantation tolerance in neonates, immune tolerance strategies have been actively pursued. It was found that T cells play a critical role in graft rejection, but can also be major players in mediating transplantation tolerance. Consequently, many experimental systems focused on T cells, often with a complete exclusion of B cells from in vivo animal models. It is now becoming clear that in addition to T cells, B cells can mediate graft rejection and transplantation tolerance. In this issue of the JCI, Khiew et al. investigated the contribution of alloreactive B cells to transplantation tolerance using a mouse cardiac transplantation model. The authors revealed a distinct tolerant B cell phenotype possessing the ability to suppress naive B cells. These data lead to a better understanding of B cell contributions to transplantation tolerance, and may inform the development of future immune tolerance protocols.

Authors

Luis Graca

×

Figure 1

The impact of transplantation tolerance on T and B cell populations.

Options: View larger image (or click on image) Download as PowerPoint
The impact of transplantation tolerance on T and B cell populations.
(A)...
(A) In murine heart transplantation, treatment with anti-CD154 antibody and donor spleen cells (costimulation blockade) at the time of transplantation leads to donor-specific tolerance. The antigen-specific tolerance is a consequence of changes in T and B cell populations. (B) Many donor-specific T cells are deleted. Other T cells acquire regulatory function (Treg) endowing them with the ability to suppress remaining donor-specific T cells (Teff). (C) B cells are mainly converted into a tolerant phenotype (Tol-B), distinct from what has been described for regulatory B (Breg) cells. Unlike Breg cells, Tol-B cells do not directly suppress T cells. However, Tol-B cells can effectively suppress other B cells sharing the same donor-antigen specificity. Overall, changes in donor-specific T and B cell populations allow suppression of immune responses targeting the donor antigens, without preventing protective immune responses against unrelated antigens. DC, dendritic cell.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts